| Bid Price | 2.05p | High Price | 2.15p |
|---|
| Ask Price | 2.10p | Low Price | 2.05p |
|---|
| Open Price | 2.13p | Spread | 2.38% |
|---|
| Prev Close | 2.13p | Volume | 2,293,785 |
|---|
Genedrive PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Jan 24, 2025 | 2.13 | 2.15 | 2.05 | 2.08 | 2,293,785 |
| Jan 23, 2025 | 2.15 | 2.20 | 2.06 | 2.13 | 2,465,999 |
| Jan 22, 2025 | 2.15 | 2.20 | 2.10 | 2.15 | 3,284,349 |
| Jan 21, 2025 | 2.17 | 2.35 | 2.15 | 2.15 | 6,980,889 |
| Jan 20, 2025 | 2.10 | 2.22 | 2.05 | 2.17 | 2,079,427 |
Genedrive PLC Information
| Name | Genedrive PLC | Index | FTSE AIM All Share |
|---|
| ISIN | GB00B1VKB244 | Epic | GDR |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASQ1 |
|---|
| Industry | Diagnostics & Research | Sector | Healthcare |
|---|
| EMS | 50,000 | Trading Status | Closed |
|---|
| Shares in Issue | 543.14 m | Prev Close | 2.13p |
|---|
| PE Ratio | | Market Cap | £11.27 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | -£0.01 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -1.438333 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 4.598196 | Quick Ratio | 3.687023 |
|---|
Genedrive PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 20/12/24 | BUY | Ian Gilham | CH | 225,000 @ £0.02 | £5,274.00 |
| 20/12/24 | BUY | Thomas Lindsay | NED | 222,222 @ £0.02 | £5,000.00 |
| 20/12/24 | BUY | Russell Shaw | FD | 1,000,000 @ £0.02 | £21,890.00 |
| 20/12/24 | BUY | Gino Miele | ED | 1,135,208 @ £0.02 | £24,975.00 |
| 15/08/24 | BUY | Ian Gilham | CH | 1,000,000 @ £0.03 | £31,000.00 |
| 15/05/24 | PLAC | Thomas Lindsay | NED | 666,666 @ £0.02 | £10,000.00 |
| 15/05/24 | PLAC | James Cheek | RES | 666,666 @ £0.02 | £10,000.00 |
| 23/02/22 | SELL | Matthew Fowler | RES | 86,957 @ £0.18 | £15,217.00 |
| 01/10/21 | PLAC | Ian Gilham | CH | 80,000 @ £0.25 | £20,000.00 |
| 01/10/21 | PLAC | Chris Yates | NED | 20,000 @ £0.25 | £5,000.00 |
Genedrive PLC News
